Suppr超能文献

在SKOV-3人卵巢癌细胞中,Src对转化生长因子-β1依赖的Smad2/3激活和PAI-1表达上调起负向调节作用。

Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.

作者信息

Wakahara Kiyoshi, Kobayashi Hiroshi, Yagyu Tatsuo, Matsuzaki Hidenori, Kondo Toshiharu, Kurita Noriyuki, Sekino Hideo, Inagaki Kiyokazu, Suzuki Mika, Kanayama Naohiro, Terao Toshihiko

机构信息

NetForce Co. Ltd., Taiko 3-1-18, Nakamura, Nagoya, Aichi 453-0801, Japan.

出版信息

J Cell Biochem. 2004 Oct 15;93(3):437-53. doi: 10.1002/jcb.20160.

Abstract

The net balance between urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) has been implicated in tumor cell invasion and metastasis. To elucidate the mechanism of the transforming growth factor-beta1 (TGF-beta1)-dependent up-regulation of PAI-1 expression, we investigated which signaling pathway transduced by TGF-beta1 is responsible for this effect. Here, we show (1) nontoxic concentrations of TGF-beta1 up-regulates uPA expression in HRA and SKOV-3 human ovarian cancer cells, (2) TGF-beta1 activates Smads (phosphorylation of Smad2 and nuclear translocation of Smad3) and subsequently up-regulates PAI-1 expression in HRA cells, whereas TGF-beta1 neither activates Smads nor up-regulates PAI-1 in SKOV-3 cells, (3) pharmacological Src inhibitor PP2 or antisense (AS) c-Src oligodeoxynucleotide (ODN) treatment significantly induces TGF-beta1-dependent activation of Smads, leading to PAI-1 synthesis, compared with controls, in SKOV-3 cells, (4) combination of TGF-beta1 and PP2, which activates PAI-1 expression and reduces uPA expression in SKOV-3, results in decreased invasiveness, (5) pharmacological inhibitors for mitogen-activated protein kinase (MAPK) (PD98059) and phosphoinositide-3-kinase (PI3K) (LY294002 and wortmannin) or AS-PI3K ODN transfection do not affect TGF-beta1-induced Smad signaling and up-regulation of PAI-1 expression in SKOV-3 cells pretreated with PP2, and (6) the induction of PAI-1 protein was partially inhibited by an inhibitor of Sp1-DNA binding, mithramycin, implicating, at least in part, Sp1 in the regulation of this gene by TGF-beta1. In conclusion, TGF-beta1-dependent activation of Smad2/3, leading to PAI-1 synthesis, may be negatively regulated by Src, but not its downstream targets MAPK and PI3K in SKOV-3 cells. These data also reflect the complex biological effect of uPA-PAI-1 system.

摘要

尿激酶型纤溶酶原激活物(uPA)与纤溶酶原激活物抑制剂1型(PAI-1)之间的净平衡与肿瘤细胞的侵袭和转移有关。为了阐明转化生长因子-β1(TGF-β1)依赖性上调PAI-1表达的机制,我们研究了TGF-β1转导的哪种信号通路介导了这一效应。在此,我们发现:(1)无毒浓度的TGF-β1上调HRA和SKOV-3人卵巢癌细胞中uPA的表达;(2)TGF-β1激活Smads(Smad2磷酸化和Smad3核转位),随后上调HRA细胞中PAI-1的表达,而TGF-β1既不激活SKOV-3细胞中的Smads,也不上调其PAI-1的表达;(3)与对照组相比,药理学上的Src抑制剂PP2或反义(AS)c-Src寡脱氧核苷酸(ODN)处理显著诱导SKOV-3细胞中TGF-β1依赖性的Smads激活,从而导致PAI-1合成;(4)TGF-β1与PP2联合使用可激活SKOV-3细胞中PAI-1的表达并降低uPA的表达,导致侵袭性降低;(5)丝裂原活化蛋白激酶(MAPK)(PD98059)和磷脂酰肌醇-3激酶(PI3K)(LY294002和渥曼青霉素)的药理学抑制剂或AS-PI3K ODN转染并不影响用PP2预处理的SKOV-3细胞中TGF-β1诱导的Smad信号传导和PAI-1表达上调;(6)Sp1-DNA结合抑制剂光神霉素部分抑制PAI-1蛋白的诱导,这表明至少部分地,Sp1参与TGF-β1对该基因的调控。总之,TGF-β1依赖性激活Smad2/3导致PAI-1合成,在SKOV-3细胞中可能受Src负调控,但不受其下游靶点MAPK和PI3K的负调控。这些数据也反映了uPA-PAI-1系统复杂的生物学效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验